Andrew W. Campbell, M.D.

Medical Director - MyMycoLab

A good diagnostic doctor listens to his patients. I am that kind of doctor. 

Thirty years ago, I started seeing many women who were sick from their silicone breast implants. Most of them eventually had their implants removed, thinking it would solve their health problems but it didn’t. I got in touch with Dr. Pierre Blais in Canada, a Ph.D. expert in breast implants. His research had shown that many implants had molds in them. I then started treating these patients with an antifungal medication and they improved tremendously. 

As my reputation grew, many people started to come see me because of molds growing in their home or workplace due to water damage. Many had gone from doctor to doctor without getting any better. These patients had all kinds of tests done, taken all kinds of pills and supplements, and countless were told “it’s all in your head”. I have helped well over 10,000 patients with health problems due to molds and mycotoxins. Everyone’s immune system is unique and different, like a fingerprint. That is why there is no one treatment, no one size fits all.

The key to the diagnosis and treatment is to see if a person has antibodies to mycotoxins from exposure to molds. These are toxins, so they have an exceedingly bad and toxic effect on health. There is not enough medical and scientific evidence to support lab test for mycotoxins in urine, which is an excretion of the body. Blood circulates everywhere, to every part, every organ in the body. That is why a blood serum test for mycotoxins is so vitally important.

I have published my findings with people affected by molds and mycotoxins in medical journals and as chapters in medical books. I have lectured on this subject at medical conferences all over the U.S., Canada, Mexico, and Europe.

In all, I have published over 90 studies, 19 of them on the effects of molds and mycotoxins in people.  If you are interested, you can look these up in the National Library of Medicine at PubMed.gov and typing in Campbell AW.

In order to keep costs low, our laboratory processing is located in Guadalajara, Mexico.


Here is a list of Dr. Campbell’s studies on Molds and Mycotoxins published in various peer-reviewed medical journals.  These can also be found in the United States Library of Medicine, aka PubMed.gov.  


  1. Campbell, AW. Lyme Disease and Mycotoxicosis: How to Differentiate Between the Two. Altern Ther Health Med. 2019 Jul;25(4):8-10.

 

  1. Lieberman A, Curtis L, Campbell AW. Development of New-Onset Chronic Inflammatory Demyelinating Polyneuropathy Following Exposure to a Water-Damaged Home With High Airborne Mold Levels: A Report of Two Cases and a Review of the Literature. J Neurol Res. 2017;7(3):59-62.

 

  1. Campbell, AW. Molds and Mycotoxins: A Brief Review. Altern Ther Health Med. 2016; 22(3):8-11.

 

  1. Campbell AW.: Molds and Mycotoxins. Altern Ther Health Med, 18(1), 8-10, January 2012.

 

  1. Brasel TL., Campbell AW., Demers RE., Ferguson BS.,  Fink J., Vojdani A., Wilson SC., Straus DC.: Detection of Trichothecene Mycotoxins in Sera from Individuals Exposed to Stachybotrys Chartarum in Indoor Environments. Arch Environ Health, 59(6), 317-323, June 2004.

 

  1. Campbell AW.; Thrasher JD.; Gray MR.; Vojdani A.: Chapter: “Mold and Mycotoxins: Effects on the Neurological and Immune Systems in Humans.” Adv Appl Microbiol (Volume 55). David C. Straus., (ed.), Published by Elsevier Inc., 2004.

 

  1. Gray MR.., Thrasher JD., Crago R., Madison RA., Arnold L., Campbell AW., Vojdani A: Chapter: “Mixed Mold Mycotoxicosis: Immunological Changes in Humans Following Exposure in Water- Damaged Buildings.” Molds and Mycotoxins.* Kaye H. Kilburn, M.D. (ed.), Published by Heldref Publications, 2004.

 

  1. Campbell AW., Thrasher JD., Madison RA., Vojdani A., Gray MR., Arnold L.: Chapter: “Neural Autoantibodies and Neurophysiologic Abnormalities in Patients Exposed to Molds in Water-Damaged Buildings.” Molds and Mycotoxins. Kaye H. Kilburn, M.D. (ed.), Published by Heldref Publications, 2004.

 

  1. Vojdani A., Thrasher JD., Madison RA., Gray MR.,   Heuser G., Campbell AW.,: Chapter: “Antibodies to Molds and Satratoxin in Individuals Exposed in Water-Damaged Buildings.” Molds and Mycotoxins. Kaye H. Kilburn, M.D. (ed.), Published by Heldref Publications, 2004.

 

  1. Campbell AW., Anyanwu EC., Mohammed M.: Evaluation of the Drug Treatment and Persistence of Onychomycosis. ScientificWorldJournal, 4:760-777, 2004.

 

  1. Anyanwu EC., Mohammed M., Campbell AW: Metabolism of Mycotoxins, Intracellular Functions of Vitamin B12, and Neurological Manifestations in Patients with Chronic Toxigenic Mold Exposures. A Review. ScientificWorldJournal, 4:736-745, 2004.

 

  1. Anyanwu EC., Campbell AW., Ehiri JE: Mycotoxins and Antifungal Drug Interactions: Implications in the Treatment of Illnesses Due to Indoor Chronic Toxigenic Mold Exposures. ScientificWorldJournal, 4:167-177, 2004.

 

  1. Campbell AW., Thrasher JD., Madison RA., Vojdani A., Gray MR., Johnson AL.: Neural Autoantibodies and Neurophysiologic Abnormalities in Patients Exposed to Molds in Water-Damaged Buildings. Arch Environ Health, 58(8), 464-474, August 2003.

 

  1. Vojdani A., Thrasher JD., Madison RA., Gray MR., Heuser G., Campbell AW: Antibodies to Molds and Satratoxin in Individuals Exposed in Water-Damaged Buildings. Arch Environ Health, 58(7), 421-432, July 2003.

 

  1. Anyanwu E., Campbell AW., Vojdani A., Ehiri JE, Akpan Al: Biochemical Changes in the Serum of Patients with Chronic Toxigenic Mold Exposures: A Risk Factor for Multiple Renal Dysfunctions. Scientific World Journal, 3(11), 1058-1064, Nov. 3, 2003.  

 

  1. Anyanwu E., Campbell A., Jones J., Ehiri J: The Neurological Significance of Abnormal Natural Killer Cell Activity in Chronic Toxigenic Mold Exposures. Scientific World Journal, 3:1128-1137, 2003.

 

  1. Campbell A, Anyanwu E, Vojdani A: Combination of High-dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis. Scientific World Journal, 3:640-646, 2003.

 

  1. Anyanwu E, Campbell A, Vojdani A: Neurophysiological Effects of Chronic Indoor Environmental Toxic Mold Exposure on Children. Scientific World Journal, 3:281-290, April 28, 2003.

 

  1. Vojdani A, Campbell A, Kashanian A, Vojdani E: Saliva Secretory IgA Antibodies Against Molds and Mycotoxins in Patients Exposed to Toxigenic Fungi. Immunopharmacol Immunotoxicol, Vol 25(4): 595-614, 2003.

 

  1. Anyanwu, E.; Campbell, A.; Vojdani, A.: Brainstem Auditory Evoked Response in Adolescents with Acoustic Mycotic Neuroma Due to Environmental Exposure to Toxic Molds. Int J Adolesc Med Health, March 2002.